These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 5763787)

  • 1. Specificity of combination between mucopeptide precursors and vancomycin or ristocetin.
    Perkins HR
    Biochem J; 1969 Jan; 111(2):195-205. PubMed ID: 5763787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The specificity of combination between ristocetins and peptides related to bacterial cell wall mucopeptide precursors.
    Nieto M; Perkins HR
    Biochem J; 1971 Oct; 124(5):845-52. PubMed ID: 4331859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.
    Nieto M; Perkins HR
    Biochem J; 1971 Aug; 123(5):789-803. PubMed ID: 5124386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative affinity of vancomycin and ristocetin for cell walls and uridine diphosphate-N-acetylmuramyl pentapeptide.
    Best GK; Grastie MK; McConnell RD
    J Bacteriol; 1970 May; 102(2):476-82. PubMed ID: 4986761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.
    Linsdell H; Toiron C; Bruix M; Rivas G; Menéndez M
    J Antibiot (Tokyo); 1996 Feb; 49(2):181-93. PubMed ID: 8621360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EVIDENCE FOR AN INITIAL ACCEPTOR OF UDP-NAC-MURAMYL-PENTAPEPTIDE IN THE SYNTHESIS OF BACTERIAL MUCOPEPTIDE.
    STRUVE WG; NEUHAUS FC
    Biochem Biophys Res Commun; 1965 Jan; 18():6-12. PubMed ID: 14265759
    [No Abstract]   [Full Text] [Related]  

  • 7. Iodinated vancomycin and mucopeptide biosynthesis by cell-free preparations from Micrococcus lysodeikticus.
    Bordet C; Perkins HR
    Biochem J; 1970 Oct; 119(5):877-83. PubMed ID: 4250137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the Streptomyces albus G DD carboxypeptidase mechanism of action of penicillin, vancomycin, and ristocetin.
    Leyh-Bouille M; Ghuysen JM; Nieto M; Perkins HR; Schleifer KH; Kandler O
    Biochemistry; 1970 Jul; 9(15):2971-5. PubMed ID: 5474798
    [No Abstract]   [Full Text] [Related]  

  • 9. The preparation of iodinated vancomycin and its distribution in bacteria treated with the antibiotic.
    Perkins HR; Nieto M
    Biochem J; 1970 Jan; 116(1):83-92. PubMed ID: 5411430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal by a specific peptide (diacetyl-alpha gamma-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations.
    Nieto M; Perkins HR; Reynolds PE
    Biochem J; 1972 Jan; 126(1):139-49. PubMed ID: 4627581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermochemistry of the interaction between peptides and vancomycin or ristocetin.
    Rodríguez-Tebar A; Vázquez D; Pérez Velázquez JL; Laynez J; Wadsö I
    J Antibiot (Tokyo); 1986 Nov; 39(11):1578-83. PubMed ID: 3793627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell wall of Bacillus licheniformis N.C.T.C. 6346. Composition of the mucopeptide component.
    Hughes RC
    Biochem J; 1968 Jan; 106(1):41-8. PubMed ID: 5721470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The killing of bacteria by cell wall inhibitors.
    Rogers HJ
    Contrib Microbiol Immunol; 1973; 1():117-34. PubMed ID: 4805300
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of 125I-labeled ristocetin binding to Micrococcus luteus cells by the peptides related to bacterial cell wall mucopeptide precursors: quantitative structure-activity relationships.
    Kim KH; Martin Y; Otis E; Mao J
    J Med Chem; 1989 Jan; 32(1):84-93. PubMed ID: 2909749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class.
    Popieniek PH; Pratt RF
    Anal Biochem; 1987 Aug; 165(1):108-13. PubMed ID: 3688425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE LOCATION OF THE MUCOPEPTIDE IN SECTIONS OF THE CELL WALL OF ESCHERICHIA COLI AND OTHER GRAM-NEGATIVE BACTERIA.
    MURRAY RG; STEED P; ELSON HE
    Can J Microbiol; 1965 Jun; 11():547-60. PubMed ID: 14346132
    [No Abstract]   [Full Text] [Related]  

  • 17. Homoserine and diaminobutyric acid in the mucopeptide-precursor-nucleotides and cell walls of some plant-pathogenic corynebacteria.
    Perkins HR
    Biochem J; 1971 Feb; 121(3):417-23. PubMed ID: 5119774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemical basis for the action of the vancomycin group of antibiotics.
    Perkins HR; Nieto M
    Ann N Y Acad Sci; 1974 May; 235(0):348-63. PubMed ID: 4369274
    [No Abstract]   [Full Text] [Related]  

  • 19. THE INTERRELATIONSHIP BETWEEN MUCOPEPTIDE AND RIBITOL TEICHOIC ACID FORMATION AS SHOWN BY THE EFFECT OF INHIBITORS.
    ROGERS HJ; GARRETT AJ
    Biochem J; 1965 Jul; 96(1):231-43. PubMed ID: 14343137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of complexes between some glycopeptide antibiotics and bacterial cell-wall analogues by electrospray- and capillary zone electrophoresis/electrospray-mass spectrometry.
    Hamdan M; Curcuruto O; Di Modugno E
    Rapid Commun Mass Spectrom; 1995; 9(10):883-7. PubMed ID: 7670152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.